The exhaustion that comes with iron deficiency in perimenopause is a particular kind of bone-deep tired that sleep does not touch — and it is so easy to chalk it up to 'just menopause' and keep pushing through. What took time to piece together was that the bleeding, the gut changes, and the inflammation were all happening at once, pulling iron out faster than any supplement could put it back. If the iron tablets are not moving the needle, there is usually a reason — and it is worth finding it.
Learn more about Rose →As progesterone levels become erratic and decline relative to estrogen, the uterine lining can build up more than usual and shed incompletely across cycles, producing periods that are significantly heavier and longer than a woman's lifetime normal. Research consistently shows that menstrual blood loss above 80 ml per cycle constitutes clinically significant iron loss, and perimenopausal cycles frequently exceed this threshold. Unlike the predictable periods of the reproductive years, these episodes can arrive without warning, making it difficult to track cumulative loss over time.
Iron depletion follows a staged process: storage iron in the liver and bone marrow drops first, then transport iron in the blood falls, and frank anemia — measurable low hemoglobin — only appears at the final stage. A woman can be profoundly depleted in ferritin, the storage form of iron, while her complete blood count still looks normal, meaning a standard anemia screen will miss the problem entirely. Symptoms like fatigue, poor concentration, and breathlessness can be severe long before any test flags a diagnosable anemia.
Estrogen receptors are present throughout the gastrointestinal tract, and estrogen has a documented role in upregulating the transport proteins — particularly duodenal cytochrome B and DMT1 — that move iron across the intestinal wall into the bloodstream. As estrogen declines during perimenopause, this absorptive machinery becomes less efficient, meaning the same dietary iron intake or supplement dose delivers less usable iron than it would have a decade earlier. This mechanism is underappreciated in clinical practice and explains why some women need meaningfully higher iron doses, or different forms, to achieve repletion.
The liver produces a hormone called hepcidin in response to inflammation, and hepcidin is the master regulator of iron traffic in the body: when it rises, it locks iron inside cells and blocks intestinal absorption. The chronic low-grade inflammation that tends to increase through midlife — driven by visceral fat, poor sleep, and the pro-inflammatory shift that accompanies estrogen decline — elevates hepcidin enough to create what clinicians call anemia of chronic disease. In this state, the body has iron but cannot access or deploy it effectively, and simply taking more iron supplements does not resolve the underlying block.
A healthy, diverse gut microbiome supports iron absorption by maintaining the slightly acidic environment in the upper intestine where iron uptake is most efficient and by producing short-chain fatty acids that support gut wall integrity. Estrogen loss is associated with a measurable reduction in microbiome diversity, and this dysbiosis can both reduce absorptive capacity and increase gut wall permeability in ways that compromise iron uptake. Women who already have digestive complaints during perimenopause are particularly vulnerable to this compounding effect.
Ferrous sulfate, the most widely prescribed iron supplement, frequently causes constipation, nausea, and stomach cramping — and constipation is already more common during perimenopause due to gut motility changes driven by declining estrogen and progesterone. When the supplement that is supposed to correct the deficiency makes daily life uncomfortable, adherence predictably falls, and the repletion process stalls. Different forms of iron — ferrous bisglycinate or liquid preparations, for example — have evidence for better tolerability and sometimes comparable absorption, though no specific brand should be selected without guidance from a clinician.
Autoimmune thyroid disease, including Hashimoto's thyroiditis, reaches its highest incidence in women during the perimenopause years, and hypothyroidism slows gastric acid production in ways that meaningfully reduce non-heme iron absorption. Thyroid peroxidase, the enzyme central to thyroid hormone synthesis, is itself iron-dependent — so iron deficiency also impairs thyroid function, creating a bidirectional cycle that worsens both conditions simultaneously. A woman being investigated for persistent iron deficiency or unexplained fatigue should have her thyroid function checked as a routine part of that workup.
Fatigue, brain fog, low mood, poor sleep quality, palpitations, and shortness of breath are all recognized symptoms of iron deficiency anemia — and they are also among the most frequently reported symptoms of perimenopause itself. When both are present simultaneously, which is common, it is nearly impossible to distinguish their contributions without testing, and it is easy for clinicians to attribute everything to hormones and miss the iron picture entirely. Addressing iron deficiency does not eliminate menopause symptoms, but it consistently reduces the severity of fatigue and cognitive complaints in women who are deficient, making the remaining hormonal symptoms easier to manage.
A routine full blood count will flag low hemoglobin and low mean corpuscular volume — the hallmarks of established iron deficiency anemia — but will not measure ferritin, the stored iron that depletes first and best predicts functional iron status. Many practitioners do not routinely include ferritin in a blood panel unless asked, and reference ranges for 'normal' ferritin vary widely between labs, with some setting the lower boundary as low as 10–12 µg/L, a level at which many women are already symptomatic. Current evidence and clinical consensus increasingly suggest that a ferritin below 30 µg/L warrants attention in a symptomatic woman, even if hemoglobin is technically within range.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.